Aging is associated with disturbances of both sleep and circadian rhythms. Nocturnal melatonin levels in the elderly are often substantially lower than in younger people. Studies have shown that high pharmacological doses of melatonin produce sleepiness and reduce sleep latency. The proposed studies will test the hypothesis that sleep disturbances of the elderly can be related to deficiencies in nocturnal melatonin secretion, and that restoration of rhythmic, high amplitude variations in circulating melatonin can improve sleep quality and quantity in the elderly without diminishing mood or performance the following morning. Elderly (60 -75 years) men and women participants (N=60) with and without symptomatic and polygraphically-confirmed insomnia will be tested under four conditions (placebo, 0.1, 0.2, 0.3 mg melatonin). Sleep quality and quantity will be polygraphically assessed along with measures of alertness, sleepiness, mood and performance. Parallel measures of cortisol and body temperature will be taken.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG013667-03
Application #
2699798
Study Section
Human Development and Aging Subcommittee 3 (HUD)
Project Start
1996-05-02
Project End
1999-12-31
Budget Start
1998-05-01
Budget End
1999-12-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
Organized Research Units
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Zhdanova, I V; Wurtman, R J; Regan, M M et al. (2001) Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab 86:4727-30
Zhdanova, I V; Raz, D J (1999) Effects of melatonin ingestion on cAMP and cGMP levels in human plasma. J Endocrinol 163:457-62
Zhdanova, I V; Simmons, M; Marcus, J N et al. (1999) Nocturnal increase in plasma cGMP levels in humans. J Biol Rhythms 14:307-13
Zhdanova, I V; Wurtman, R J; Wagstaff, J (1999) Effects of a low dose of melatonin on sleep in children with Angelman syndrome. J Pediatr Endocrinol Metab 12:57-67
Zhdanova, I V; Wurtman, R J; Balcioglu, A et al. (1998) Endogenous melatonin levels and the fate of exogenous melatonin: age effects. J Gerontol A Biol Sci Med Sci 53:B293-8
Zhdanova, I V; Cantor, M L; Leclair, O U et al. (1998) Behavioral effects of melatonin treatment in non-human primates. Sleep Res Online 1:114-8
Zhdanova, I V; Wurtman, R J (1997) Efficacy of melatonin as a sleep-promoting agent. J Biol Rhythms 12:644-50